Recovery periods important to maintain the health and well-being of medical professionals

A study assessed the psychobiological functioning of 27 Pre-Hospital Emergency Medical doctors and paramedics over two weeks.

Extreme weather impacts HIV prevention and treatment access

New challenges in HIV prevention and care are emerging due to climate change, according to a review published earlier this month in Current Opinions in

January 8, 2025

Apellis and Sobi land another late-stage win for rare kidney disease drug

Empaveli, the kidney disease drug from Apellis Pharmaceuticals and Sobi, reported a Phase 3 trial success that could help the treatment keep pace with a

August 9, 2024

Ipsen’s elafibranor recommended for use in patients with rare liver disease

Ipsen announced today that the National Institute for Health and Care Excellence (NICE) has recommended elafibranor 80mg tablets for the treatment of PBC in combination

October 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.